pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

428 catalysts · 3,045 8k filing · 572 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×from 2026-04-02×clear all
type
  • 8k filing3,045
  • earnings572
  • grant249
  • approval179
  • phase 2 completion172
  • drug shortage133
device 510k
116
  • phase 1 completion73
  • phase 2 initiation62
  • device pma59
  • therapy area

    no tagged catalysts yet

    Week of Mar 30, 2026

    50
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalBoehringer Ingelheim Corp

    Sponsor: DR REDDYS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoEYLEA HD (AFLIBERCEPT) — FDA approvalEYLEA HD

    Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

    full page →EYLEA HD →fda approvals ↗
    ›Apr 2, 2026approval131d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: DEXCEL. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: APOTEX. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026grant131d agoYALE UNIVERSITY — Novel Treg inactivating approach for cancer immunotherapy via targeted protei...

    CA grant. $482,312. PI: Wei Hu

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Interrogating Erythroid Differentiation and BCL-XL Axis in TP53-mutated Acute...Albert Einstein College of Medicine

    CA grant. $442,816. PI: Hussein Abbas

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CALIFORNIA SANTA CRUZ — Exploration of the bacterial polyadenylase PAP I as an antimicrobial drug target

    AI grant. $430,375. PI: Victoria Auerbuch Stone

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoRESEARCH INST NATIONWIDE CHILDREN'S HOSP — Genetically and metabolically defining high-risk neuroblastoma to exploit eff...

    CA grant. $608,558. PI: Ruoning Wang

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoLA JOLLA INSTITUTE FOR IMMUNOLOGY — Human upper airway immune memory kinetics and durability against respiratory ...Dawn Sea Therapeutics

    AI grant. $159,300. PI: Sydney Ilima Ramirez

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CHICAGO — Dissecting the intrinsic role of SLC4A2 in the development of liver inflammat...

    AI grant. $164,000. PI: Axel Rolando Concepcion Gonzalez

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoLOYOLA UNIVERSITY CHICAGO — Anti-inflammatory effects of reverse transcriptase inhibitors during bacteria...AimMax Therapeutics Inc

    AI grant. $158,800. PI: Karthik Hullahalli

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CHICAGO — Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus

    AR grant. $582,695. PI: Jill P Buyon

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Cellular and circuit mechanisms underlying the generation, regulation, and fl...

    MH grant. $126,900. PI: Lynn Yap

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CHICAGO — Investigating the immunomodulatory role of the Nonclassical MHC Molecule HLA-...

    AI grant. $818,457. PI: Erin June Adams

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Neutralizing antibody pressure on the evolution of SARS-CoV-2 variants."

    AI grant. $194,160. PI: Ian Alexander Mellis

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoFRED HUTCHINSON CANCER CENTER — Modeling SARS-CoV-2 variant emergence from immunocompromised hosts

    AI grant. $161,946. PI: Katherine Owens

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoROCHESTER INSTITUTE OF TECHNOLOGY — Surveillance of antibiotic resistance in natural commensal Neisseria populati...

    AI grant. $561,410. PI: Crista Burke Wadsworth

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoEMORY UNIVERSITY — The Role of Clonal Hematopoiesis in Lung Cancer: Immune Dysregulation and The...Emory University

    CA grant. $646,181. PI: Janghee Woo

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CALIFORNIA-IRVINE — Mechanisms of immunosuppression triggered by checkpoint blockade immunotherapy

    CA grant. $648,626. PI: Francesco Marangoni

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CALIFORNIA-IRVINE — Protoacoustic Imaging for 3D Mapping the Bragg Peak in Real Time during Proto...

    CA grant. $648,049. PI: Yong Chen

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoPENNSYLVANIA STATE UNIVERSITY, THE — Statistical Models for Estimating Spatial and Sub-population HIV Epidemics

    AI grant. $842,720. PI: Le Bao

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoCINCINNATI CHILDRENS HOSP MED CTR — Frontiers at the edge: Subpleural fibroblasts orchestrate pulmonary fibrosis ...

    HL grant. $249,000. PI: Le Xu

    full page →nih reporter ↗
    ›Apr 3, 2026approval130d agoGLYCOPYRRONIUM TOSYLATE — FDA approvalJourney Medical Corp

    Sponsor: PADAGIS US. Form: CLOTH. Route: TOPICAL

    full page →fda approvals ↗
    ›Apr 3, 2026approval130d agoPHENYLEPHRINE HYDROCHLORIDE — FDA approvalPHENYLEPHRINE HYDROCHLORIDE

    Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS

    full page →PHENYLEPHRINE HYDROCHLORIDE →fda approvals ↗
    ›Apr 3, 2026approval130d agoTYVASO (TREPROSTINIL) — FDA approvalUNITED THERAPEUTICS Corp

    Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION

    full page →fda approvals ↗
    ›Apr 3, 2026approval130d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 3, 2026grant130d agoOHIO STATE UNIVERSITY — A high-throughput, multimodal strategy to improve variant classification

    HG grant. $174,430. PI: Megan Lancaster

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoDUKE UNIVERSITY — Mentoring in Anti-Infective Clinical Pharmacology and PharmacometricsDuke University

    AI grant. $203,556. PI: Daniel Gonzalez

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoUNIVERSITY OF NOTRE DAME — Species-specific Yeast RNAi Pesticides for Sand Fly Control

    AI grant. $464,176. PI: MARY A MCDOWELL

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoWASHINGTON UNIVERSITY — An in vitro screening system for genitalia development

    ES grant. $419,676. PI: Liang Ma

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoSLOAN-KETTERING INST CAN RESEARCH — Role of Arid1a in NK cell development and antiviral immunity

    AI grant. $46,564. PI: Mariah Lee

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoWAYNE STATE UNIVERSITY — Mechanisms underlying Phage-Antibiotic Synergy and Resistance in Daptomycin-R...Baxter Healthcare Corp

    AI grant. $455,719. PI: Michael Joseph Rybak

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoUNIVERSITY OF MIAMI SCHOOL OF MEDICINE — Beginning genetic interventions in infants (BEGIN)

    HG grant. $3,151,302. PI: PANKAJ B AGRAWAL

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoUNIVERSITY OF COLORADO — Understanding mechanisms of RNA polymerase II transcriptional termination

    GM grant. $307,854. PI: James Goodrich

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoCINCINNATI CHILDRENS HOSP MED CTR — Predictive approaches to mitigate risk of hepatotoxicity of drugs in children

    HD grant. $445,500. PI: Bhagwat Prasad

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Role of mRNA internal 2′-O methylation in post-transcriptional regulationNorthwestern University

    GM grant. $440,000. PI: Yang Yi

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoMASSACHUSETTS GENERAL HOSPITAL — Endorsed ISMRM Workshop on MRI of NeuromodulationMassachusetts General Hospital

    EB grant. $10,000. PI: Lucia Isabel Navarro de Lara

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoUNIVERSITY OF WISCONSIN-MADISON — Hijacking the neonatal Fc receptor: the novel biology of arterivirus entry, t...

    AI grant. $615,446. PI: Adam Lee Bailey

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoWISTAR INSTITUTE — Myeloid cell-derived interleukin 1b promotes chemoresistance in metastatic ov...

    CA grant. $473,624. PI: Nan Zhang

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoUNIVERSITY OF TEXAS AT AUSTIN — CD44 splice variants as novel antibody-targets for advanced breast cancer

    CA grant. $668,878. PI: JENNIFER A MAYNARD

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoUNIVERSITY OF COLORADO — Regulatory nucleic acid interactions and telomere complexes

    GM grant. $495,480. PI: DEBORAH S. WUTTKE

    full page →nih reporter ↗
    ›Apr 3, 2026grant130d agoDREXEL UNIVERSITY — Investigating the Role of Phthalates, Phenols, and Their Sources on Phenotypi...

    ES grant. $111,199. PI: Marisa Ann Patti

    full page →nih reporter ↗
    ← prev
    page 1 of 9
    next →
    $UTHR529.66-1.70%
    $DERM6.4400+0.16%
    $RDHL0.7390+6.64%
    $REGN808.05+3.02%